Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibiotics

Keats, KR; Stitt, TM; Chastain, DB; Jivan, BP; Matznick, E; Waller, JL; Clemmons, AB

Stitt, TM (corresponding author), Univ Georgia, Coll Pharm, 914 New Bailie St,HM Bldg, Augusta, GA 30912 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, ; ():

Abstract

Purpose To determine the impact of Clostridioides difficile infection (CDI) treatment duration on CDI recurrence in hematology/oncology patients recei......

Full Text Link